このページの先頭

洛和会音羽病院

交通アクセス

糖尿病・内分泌・生活習慣病センター 研究業績

最近9年間における英文論文業績

“Physiological concentration of atrial natriuretic peptide induces endothelialregeneration in vitro.”
Kook H, Itoh H, Choi BS, Sawada N, Doi K, Hwang TJ, Kim KK, Arai H, Baik YH,Nakao K.
Am J Physiol Heart Circ Physiol. 2003;284(4):H1388-97.
“Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress. ”
Masatsugu K, Itoh H, Chun TH, Saito T, Yamashita J, Doi K, Inoue M, Sawada N, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, Yurugi T, Nakao K.
Regul Pept. 2003 28;111 (1-3):13-9.
“Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples.”
Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F, Kangawa K.
Clin Chem. 2004;50(6):1077-80.
“Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.”
Tanaka T, Fukunaga Y, Itoh H, Doi K, Yamashita J, Chun TH, Inoue M, Masatsugu K, Saito T, Sawada N, Sakaguchi S, Arai H, Nakao K.
Eur J Pharmacol. 2005:31;508(1-3):255-65.
“Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK). ”
Saito T, Itoh H, Yamashita J, Doi K, Chun TH, Tanaka T, Inoue M, MasatsuguK, Fukunaga Y, Sawada N, Sakaguchi S, Arai H, Tojo K, Tajima N, Hosoya T, Nakao K.
Regul Pept. 2005;127(1-3):159-67.
“Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients.”
Majima T, Komatsu Y, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, Nakao K.
Osteoporos Int. 2005;16(8):907-13.
“Papillary thyroid carcinoma without metastases manifesting as an autonomously functioning thyroid nodule. ”
Majima T, Doi K, Komatsu Y, Itoh H, Fukao A, Shigemoto M, Takagi C, Corners J, Mizuta N, Kato R, Nakao K.
Endocr J. 2005 ;52(3):309-16.
“Anaplastic thyroid carcinoma associated with Graves' disease. ”
Majima T, Komatsu Y, Doi K, Shigemoto M, Takagi C, Fukao A, Kojima M, Tamaki H, Ito J, Nakao K.
Endocr J. 2005 ;52(5): 551-7.
“Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease. ”
Majima T, Komatsu Y, Doi K, Takagi C, Shigemoto M, Fukao A, Morimoto T,Corners J, Nakao K.
Osteoporos Int. 2006;17(7):1103-10.
“Safety and efficacy of low-dose pioglitazone (7.5 mg/day) vs. standard-dose pioglitazone (15 mg/day) in japanese women with type 2 diabetes mellitus.”
Majima T, Komatsu Y, Doi K, Shigemoto M, Takagi C, Fukao A, Corners J, Nakao K.
Endocr J. 2006 ;53(3):325-30.
“Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease. ”
Majima T, Komatsu Y, Doi K, Takagi C, Shigemoto M, Fukao A, Morimoto T, Corners J, Nakao K.
J Bone Miner Metab. 2006;24(2):105-13.
“Purification and characterization of feline ghrelin and its possible role. ”
Ida T, Miyazato M, Naganobu K, Nakahara K, Sato M, Lin XZ, Kaiya H, Doi K, Noda S, Kubo A, Murakami N, Kangawa K.
Domest Anim Endocrinol. 2007;32(2):93-105.
“Impaired flow-medeiated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. ”
Makino H. Doi K. Hiuge A. Nagumo A. Okada S. Miyamoto Y. Suzuki M. Yoshimasa Y.
Diabetes Res Clin Pract. 2008;79(1):177-82

 

サイトマップ




交通アクセスマップ

〒607-8062
京都市山科区音羽珍事町2
075(593)4111(代)

詳しくはこちら


京都府子宮頸がん検診啓発キャンペーン

ページトップ